Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FY8TE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,095
Award facts
- Contract value 100% obligated
- $11,095.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,095.16 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for Enbrel 50 mg/ml SureClick auto-injectors on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order represents a non-competitive award issued under an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The award is a child order under the parent company Cencora, Inc., which operates AmerisourceBergen and holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031.
This delivery order for the immunosuppressant medication Enbrel represents a routine fulfillment of pharmaceutical supply needs under DLA's established pharmaceutical prime vendor contract. Enbrel, used primarily for the treatment of rheumatoid arthritis and other autoimmune conditions, is a critical therapeutic agent for federal healthcare beneficiaries. The single-award IDC with Cencora enables the Defense Logistics Agency to efficiently procure a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military treatment facilities and defense health programs globally.
Quick answers
Who was awarded contract SPE2DR26FY8TE?
SPE2DR26FY8TE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FY8TE worth?
The government has obligated $11,095 on SPE2DR26FY8TE.
Is contract SPE2DR26FY8TE an order under another contract?
Yes. SPE2DR26FY8TE is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8TE competed?
The extent of competition for SPE2DR26FY8TE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award